News and events from world of cardiorenal medicine.
Conference
The 3rd Immuno-Metabolic Mechanisms of Atherosclerosis Conference
1st – 4th May 2022
Scientific Chairs Christoph Binder (Medical University of Vienna), Ziad Mallat (University of Cambridge) & Eicke Latz (University of Bonn) are coming together once again to host the 3rd Immuno-Metabolic Mechanisms of Atherosclerosis Conference. The meeting will be taking place in person from 01-04 May 2022 at the Fiesta Americana Tulkal Riviera Maya, Mexico.
Building on the success of the previous meetings, the main goal of this meeting is to provide attendees with a comprehensive overview of current research on atherosclerosis with a focus on the latest and most exciting developments in the immuno-metabolic mechanisms that govern disease initiation and progression. There is little doubt that the next most exciting therapy to combat cardiovascular disease will be based on targeting biological pathways that will have been discussed during this conference.
Seven sessions are planned and will highlight the following major research areas:
The deadlines for submitting a talk or a poster are as follows:
New tool
KDIGO Launches New Implementation Tools for Diabetes Management in CKD
Kidney Disease Improving Global Outcomes (KDIGO) launched two new implementation tools based on the 2020 Clinical Practice Guideline for the Management of Diabetes in Chronic Kidney Disease (CKD): the Diabetes in CKD Visual Guideline and the Diabetes in CKD Infographic Set.
Acknowledging the often lengthy and complex nature of clinical practice guidelines, the KDIGO Diabetes in CKD Visual Guideline and Infographic Set are intended to make key recommendations and practice points more quickly accessible and readily understandable. Topics include comprehensive care, glycemic monitoring and targets, lifestyle and antihyperglycemic interventions, approaches to self-management, and optimal models of care.
The KDIGO Diabetes in CKD Guideline Update is currently underway and is scheduled to publish in 2022. The Diabetes in CKD Visual Guideline and Infographic Set will be updated to include the latest science and recommendations from the Guideline.
Visit the KDIGO Diabetes in CKD Guideline website to download the new implementation tools and other resources.
Recommendations
Tackling Chronic Kidney Disease at a European level
The European Kidney Health Alliance (EKHA) is a common effort by stakeholders to propose solutions for the challenges of Chronic Kidney Disease in Europe.
info@ekha.eu
In Europe, 100 million people suffer from chronic kidney disease (CKD) the incidence of CKD worldwide is estimated at 700-800 million people. It is estimated that CKD will become the fifth leading cause of death globally by 2040.
The best-known causes of CKD are hypertension, cardiovascular disease and diabetes. However, cancer, liver and autoimmune diseases, pre-eclampsia and infections are also risk factors for CKD. In addition, the risk of Acute Kidney Injury (AKI) increases with age and frailty. Elderly patients with AKI often require maintenance dialysis in the following months or years. In addition to ageing, poor diet, smoking, physical inactivity, obesity and excess salt contribute greatly to the development of CKD.
Annual cost
Costs per patient increase as CKD worsens and reaches more advanced stages. It is estimated that CKD alone increases the cost of many other chronic diseases by a factor greater than two. The overall costs of CKD are at least as high as or higher than those of cancer and diabetes. These costs are estimated at 140 billion euros per year in Europe. Among the Renal Replacement Therapy (RRT) options, in-centre haemodialysis is the most common treatment option, although it has the highest per-patient costs. In Europe, annual reimbursement per country can be as high as €80,000/patient.
Recommendations for the French Presidency of the Council of the European Union (January-June 2022) have recently been made in a Document on behalf of the European Kidney Health Alliance (EKHA), the French- speaking Society of Nephrology, Dialysis and Transplantation (SFNDT), France Rein and Renaloo.
Webinar
Practical considerations in managing patients with cardiorenal disease
The Cardiorenal Forum 16th ASM took place on 8th October 2021
Dr Sarah Birkhoelzer, Professor Paul Kalra, Professor Philip Kalra, Dr Smeeta Sinha, Dr Sue Piper, Dr Rosita Zakeri, Dr Amar Puttanna, Ms Maggie Simpson, Dr Austin Chukwu, Dr Paul Hamilton, Sir John Cunningham, Dr Matt Dewhurst, Ms Sue Scott, Dr Sara Boyce, Dr Shirley Sze
Webinar
Heart failure in pandemic times: assessing evidence for treating iron deficiency
This webinar took place on 21st April 2021
Professor Sunil Bhandari, Ms Nicola Bowers, Dr Patricia Campbell, Professor John Cleland, Dr Sue Piper
Webinar
Cardiorenal Masterclass: Intravenous iron in cardiorenal disease
This webinar took place on 7th December 2020
Dr Caroline Evans, Dr Matthew Graham-Brown, Professor Paul Kalra, Professor Philip Kalra, Ms Sue Scott, Professor Myles Wolf
Webinar
Care of the cardiorenal patient: a focus on RAAS inhibition and management of hyperkalaemia
This webinar took place on 22nd October 2020
Ms Carys Barton, Ms Janine Beezer, Dr Patricia Campbell, Professor Paul Kalra, Professor Philip Kalra, Dr Kieran McCafferty
Webinar
A practical approach to improving clinical outcomes for patients with cardiorenal disease
This webinar took place on 9th October 2020
Professor Steve Bain, Professor Paul Kalra, Professor Philip Kalra, Professor Mark Petrie, Ms Jackie Price, Professor David Wheeler, Dr Anthony Wierzbicki
Webinar
Cardiorenal Masterclass: Intravenous iron in cardiovascular patients
This webinar took place on 29th September 2020
Dr Chris Allen, Dr Caroline Evans, Dr Paul WX Foley, Professor Paul Kalra, Professor Philip Kalra, Ms Sue Scott
Webinar
Providing key cardiorenal care during and after the COVID-19 pandemic
This webinar took place on 18th May 2020
Ms Carys Barton, Professor Paul Kalra, Professor Philip Kalra, Professor John McMurray, Dr Geraint Morton
The Cardiorenal Forum (CRF) is an independent group formed in 2006. The key objective of the group is to highlight the important clinical overlap that exists between patients presenting with a primary cardiovascular or renal problem. Our annual scientific meeting is our main event to bring together all involved in the management of such patients to share ideas and learn more about how to deliver high quality care. In 2020 we are delighted to be rolling out practical digital activities to focus on challenging aspects of managing cardiorenal patients
